Table 1. Characteristics of BMT... | American Society of Hematology

Table 1.

Characteristics of BMT Recipients at the Time of BAL

Recipient No.	Age (yr)	Sex		Primary Diagnosis	Grade of Acute GVHD	Type of Conditioning	Day of BAL
Recipient No.	Age (yr)	Donor	Recipient	Primary Diagnosis	Grade of Acute GVHD	Type of Conditioning	Day of BAL
1	20	F	F	CML	0	I	24
2	36	M	F	AML	I	III	32, 83
3	17	M	M	SAA	0	II	34
4	20	F	F	AML	I	I	34
5	19	F	M	MDS	0	I	35
6	24	F	M	MDS	0	I	41
7	22	M	M	ALL	I	III	41
8	20	M	M	ALL	I	III	41, 69
9	41	M	F	CML	0	I	41
10	25	F	F	AML	0	I	43
11	37	F	F	CML	0	I	46
12	26	F	M	SAA	0	II	47
13	20	M	M	CML	0	I	47
14	39	M	F	CML	0	I	48
15	29	M	M	SAA	0	II	48
16	23	F	M	ALL	I	III	48
17	33	M	M	ALL	0	III	48, 76
18	38	F	M	MDS	0	I	55
19	38	M	M	CML	I	I	55
20	26	M	M	CML	0	I	55
21	42	M	M	CML	II	I	56
22	31	F	F	CML	0	I	65
23	27	F	F	AML	0	I	69
24	27	F	F	CML	0	I	83

Recipient No.	Age (yr)	Sex		Primary Diagnosis	Grade of Acute GVHD	Type of Conditioning	Day of BAL
Recipient No.	Age (yr)	Donor	Recipient	Primary Diagnosis	Grade of Acute GVHD	Type of Conditioning	Day of BAL
1	20	F	F	CML	0	I	24
2	36	M	F	AML	I	III	32, 83
3	17	M	M	SAA	0	II	34
4	20	F	F	AML	I	I	34
5	19	F	M	MDS	0	I	35
6	24	F	M	MDS	0	I	41
7	22	M	M	ALL	I	III	41
8	20	M	M	ALL	I	III	41, 69
9	41	M	F	CML	0	I	41
10	25	F	F	AML	0	I	43
11	37	F	F	CML	0	I	46
12	26	F	M	SAA	0	II	47
13	20	M	M	CML	0	I	47
14	39	M	F	CML	0	I	48
15	29	M	M	SAA	0	II	48
16	23	F	M	ALL	I	III	48
17	33	M	M	ALL	0	III	48, 76
18	38	F	M	MDS	0	I	55
19	38	M	M	CML	I	I	55
20	26	M	M	CML	0	I	55
21	42	M	M	CML	II	I	56
22	31	F	F	CML	0	I	65
23	27	F	F	AML	0	I	69
24	27	F	F	CML	0	I	83

Abbreviations: CML, chronic myelogenous leukemia; SAA, severe aplastic anemia; AML, acute myelogenous leukemia; MDS, myelodysplastic syndrome; ALL, acute lymphocytic leukemia; aGVHD, acute graft-versus-host-disease; I, busulfan + cyclophosphamide; II, cyclophosphamide + total lymphocyte irradiation; III, cytosine arabinoside + cyclophosphamide + total body irradiation.

View Large

This Feature Is Available To Subscribers Only